In vivo migration of mesenchymal stem cells.
10.7534/j.issn.1009-2137.2014.02.050
- Author:
Hong LI
1
;
Xu-Guang GAO
2
;
Long LU
2
;
Yu-Shan BAI
3
;
Ning MAO
4
Author Information
1. Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences,Beijing 100850, China.
2. Nanyuan Airport of Chinese Air Force, Beijing 100076, China.
3. College of Science, Liaoning Technical University, Fuxin 123000, Liaoning Province, China.
4. Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences,Beijing 100850, China. E-mail: mesenchymalstemcells@yahoo.com.
- Publication Type:Journal Article
- MeSH:
Animals;
Cell Movement;
Humans;
Mesenchymal Stromal Cells;
cytology
- From:
Journal of Experimental Hematology
2014;22(2):534-537
- CountryChina
- Language:Chinese
-
Abstract:
Mesenchymal stem cells (MSC) have the capacities of low immunogenicity, multiple differentiation, hematopoietic supporting and immunoregulation. And due to their relative ease of availability and ex vivo expansion, the applications of MSC in the prevention and treatment of clinical disease have been rapidly expanded in the recent years. However, increasing investigations indicate that intravenously infused MSC widely distribute to various organs of the recipients. The two intended clinical goals of adoptive cellular therapy reached to the greatest efficiency. Therefore, the ideal candidate cells showed to have the capacity of site-specific relocation in vivo. In this review, the distribution characteristics of infused MSC and the recent research advances on the strategies to enhance targeted migration of MSCs are summarized.
